Clinical Trial Update: Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy [Phase 2]

View source ↗

Summary

Phase 2 rollover study evaluating efficacy, safety, and tolerability of eteplirsen in Duchenne Muscular Dystrophy completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• eteplirsen (eteplirsen)

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 2 | Status: COMPLETED | Results posted: 2019-07-10